AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionCyndeo Wealth Partners, LLC
Latest Disclosed Ownership136,906 shares
Latest Disclosed Value $ 29,775,709
Cyndeo Wealth Partners, LLC reports 3.80% increase in ownership of ABBV / AbbVie Inc.

On April 13, 2026 - Cyndeo Wealth Partners, LLC filed a 13F-HR form disclosing ownership of 136,906 shares of AbbVie Inc. (MX:ABBV) valued at $29,775,709 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 7, 2026 disclosing 131,890 shares of AbbVie Inc.. This represents a change in shares of 3.80% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F ABBVIE COM 00287Y109 136,906 5,016 3.80 29,776 -1.19 1.5664
2026-01-07 2025-12-31 13F ABBVIE COM 00287Y109 131,890 -50 -0.04 30,136 -1.36 1.6246
2025-10-10 2025-09-30 13F ABBVIE COM 00287Y109 131,940 706 0.54 30,549 25.41 1.6984
2025-07-24 2025-06-30 13F ABBVIE COM 00287Y109 131,234 1,536 1.18 24,360 -10.36 1.4443
2025-04-17 2025-03-31 13F ABBVIE COM 00287Y109 129,698 -7,215 -5.27 27,174 11.69 1.7839
2025-01-21 2024-12-31 13F ABBVIE COM 00287Y109 136,913 954 0.70 24,329 -9.39 1.6446
2024-10-18 2024-09-30 13F ABBVIE COM 00287Y109 135,959 -4,914 -3.49 26,849 11.12 1.8753
2024-07-30 2024-06-30 13F ABBVIE COM 00287Y109 140,873 3,178 2.31 24,163 -3.64 1.8922
2024-04-17 2024-03-31 13F ABBVIE COM 00287Y109 137,695 716 0.52 25,074 18.12 2.0853
2024-01-12 2023-12-31 13F ABBVIE COM 00287Y109 136,979 10,863 8.61 21,228 12.92 1.9644
2023-10-10 2023-09-30 13F ABBVIE COM 00287Y109 126,116 -18,670 -12.89 18,799 -3.63 1.9593
2023-07-27 2023-06-30 13F ABBVIE COM 00287Y109 144,786 7,817 5.71 19,507 -10.63 2.0388
2023-04-25 2023-03-31 13F/A-1 ABBVIE COM 00287Y109 136,969 37,296 37.42 21,829 35.51 2.3529
2023-04-21 2023-03-31 13F ABBVIE COM 00287Y109 136,969 37,296 708 0.0770
2023-01-25 2022-12-31 13F ABBVIE COM 00287Y109 99,673 99,673 16,108 1.8917
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.